Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference17 articles.
1. AJCC cancer staging handbook;Greene,2002
2. NCCN Task Force Report: adjuvant therapy for breast cancer;Carlson;J Natl Compr Canc Netw,2006
3. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;Pestalozzi;Ann Oncol,2008
4. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer;Goldhirsch;Ann Oncol,2007
5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Androgen receptor expression and its prognostic value in T1N0 luminal/HER2- breast cancer;Future Oncology;2022-05
2. Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment;Frontiers in Oncology;2021-02-19
3. Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer;Breast Cancer;2020-08-11
4. Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?;Frontiers in Oncology;2020-05-12
5. Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis;Oncotarget;2017-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3